Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Aaron M. Mohs, Ph.D. - 1 Aaron M. Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center Omaha, NE 68198 Email: [email protected] Phone: (402)-559-4336 APPOINTMENTS 2015- Assistant Professor, University of Nebraska Medical Center Department of Pharmaceutical Sciences 2015- Adjunct Assistant Professor of Biomedical Engineering Wake Forest University Health Sciences 2011-2015 Assistant Professor, Wake Forest University Health Sciences Wake Forest University – Virginia Tech School of Biomedical Engineering and Sciences, Department of Biomedical Engineering (primary), Institute for Regenerative Medicine (joint), and Cancer Biology (joint) 2011-2012 Senior Scientific Consultant, Spectropath, Inc., Atlanta, GA 2006-2011 Center of Cancer Nanotechnology Excellence Distinguished Fellowship at Emory University–Georgia Institute of Technology, Wallace H. Coulter Department of Biomedical Engineering. Advisor: Dr. Shuming Nie 2002-2006 Graduate Student and Teaching Assistant at the University of Utah, Department of Pharmaceutics and Pharmaceutical Chemistry. Advisor: Dr. Zheng-Rong Lu 2000-2002 Undergraduate Research and Teaching Assistant at St. John’s University/ College of St. Benedict, Chemistry Department. Advisor: Dr. Chris Schaller EDUCATION/TRAINING 2011 Postdoctoral Fellow, Biomedical Engineering, at Emory University–Georgia Institute of Technology, Atlanta, GA. Emphasis in nanotechnology and optical imaging for image-guided surgery. Mentor: Dr. Shuming Nie, PhD 2006 Ph.D., Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT. Dissertation: Biodegradable Macromolecular Contrast Agents for Magnetic Resonance Imaging. Mentor: Dr. Zheng-Rong Lu, PhD 2002 B.A., Chemistry, St. John’s University/College of St. Benedict, Collegeville, MN RESEARCH FUNDING On-going 2014-2018 R01 EB019449; Awarded by the National Institute of Biomedical Imaging and Bioengineering. Aaron M. Mohs, Ph.D. - 2 Project Title: Hyaluronic Acid Based Nanoparticles for Targeted Image-Guided Tumor Surgery. (Role: PI) 2010-2015 R00 CA153916; Pathway to Independence Award in Cancer Nanotechnology Research; Awarded by National Institutes of Health/National Cancer Institute. Project Title: Nanotechnology for minimally invasive for cancer detection and resection. (Role: PI) 2014-2015 WFU Comprehensive Cancer Center - School of Biomedical Engineering and Sciences Joint Pilot Award. Project Title: Nanoparticle-Based Delivery of Novel Fatty Acid Synthase Inhibitors. (Role: co-PI) Completed 2014-2015 Promoting Innovative Discoveries Pilot; Awarded by the Wake Forest Institute for Regenerative Medicine Project Title: Controlled Release Biomaterials for IL-35 Secreting Mesenchymal Stromal Cells for the Treatment of Type I Diabetes. (Role: PI) 2011-2015 North Carolina State Grant; Goal: The North Carolina General Assembly has authorized funds to provide support for Regenerative Medicine. The goal of this project is to apply the science of regenerative medicine to civilians, battlefield injuries and helping resolve the shortage of donated organs available for transplant. (Role: co-I) 2010-2014 R01 HL098912; Awarded by National Institutes of Health/National Heart Lung and Blood Institute Project Title: Optical Molecular Tomography for Regenerative Medicine (Role: co-I) 2012-2013 Pilot Seed Grant; Awarded by the Wake Forest Institute for Regenerative Medicine Project Title: New Near Infrared Imaging Method to Detect Genetically Labeled Cells Using A Nerve/Muscle Construct Model (Role: PI) LEADERSHIP/AWARDS 2014 Wake Forest Comprehensive Cancer Center Nominee, Pew-Stewart Scholars Program for Cancer Research 2014 Vice-Chair, Regenerative Imaging and Sensing Working Group; Tissue Engineering and Regenerative Medicine International Society 2011-2012 Chair, Nanomaterials/nanoformulations Working Group, NCI Alliance for Nanotechnology in Cancer 2010 Innovation of the Year (Integrated Imaging and Spectroscopy System for ImageGuided Surgery) – awarded by the Emory Office of Technology Transfer 2006-2011 Emory-Ga. Tech Center for Cancer Nanotechnology Excellence Distinguished Fellowship 2006 Wolf Prize – awarded to a University of Utah College of Pharmacy graduate student for excellence in teaching, highest award given by the College of Pharmacy Aaron M. Mohs, Ph.D. - 3 2006 Jeffrey A. Fox Award – awarded to University of Utah, Pharmaceutics graduate student for dedication and service to department 2005 PhRMA Foundation Predoctoral Fellowship awarded by the PhRMA Foundation, Washington, DC 2005 Vice-Chair, Student Advisory Committee, Pharmaceutics and Pharmaceutical Chemistry, University of Utah 2002 Enzon Fellowship awarded by Enzon Inc., Pistacaway, NJ 1998-2002 President’s Scholarship – awarded by St. John’s University, based on academic achievement, service, and leadership 1998-2002 Recognition Scholarship for Students in Science – awarded by St. John’s University, based on academic achievement in science 1999 - 2000 Siehl Scholarship – awarded by St. John’s University for academic excellence and leadership 2000 St. John’s University Study Abroad Program at the University of Salzburg RESEARCH INTERESTS Areas of Expertise Planned and implemented development of fluorescent and Raman contrast agents and optical instrumentation for image-guided surgical oncology Developed self-assembled nanoparticles that solublize and stabilize fatty acid synthase inhibitors Developed near infrared fluorescent cell lines for in vitro and in vivo tracking in regenerating tissue Evaluate vascularization in regenerating tissue using novel angiographic MRI methodologies Evaluated the chemical and biological mechanism of toxicity of novel nanoparticles, especially quantum dots, as a function of core elements and surface coating Developed nanoparticles as model carriers for biomedical applications, proton-resistant quantum dots as model carriers for oral drug delivery Synthesized and characterized biodegradable Gd(III)-based polydisulfide magnetic resonance imaging (MRI) contrast agents Characterized in vivo imaging properties of blood pool MRI contrast agents, including MR angiography and dynamic contrast-enhanced MRI techniques, pharmacokinetics, and biodistribution Synthesized and characterized nitrogenous bidentate ligands for molybdenum complexation Evaluated protein stability in injectable formulations and the possible interaction of silicon by using DSC, fluorescence spectroscopy, and circular dichroism Aaron M. Mohs, Ph.D. - 4 Technical Experience Polymer and nanoparticle synthesis and surface coating development, small molecule synthesis, oxygen free environments, including dry-box techniques and Schlenk lines Skilled in chemical characterization techniques, including TEM, XRD, SEC/GPC/HPLC, MRI, NMR, Raman, IR, and Fluorescence spectroscopy, ICP-OES, ICP-MS, ESI and MALDITOF MS, DSC, DLS, and circular dichroism Skilled in tissue culture techniques, including viability assays, cell staining, DNA microarray, confocal microscopy, flow cytometry, gel electrophoresis Performed small animal surgical procedures, including jugular vein cannulation, pharmacokinetic modeling, biodistribution, and in vivo metabolism studies Experience with Microsoft Word, Excel, and PowerPoint, Prism, SigmaPlot, Origin, Matlab, IDL, and numerous Adobe software applications TEACHING/MENTORING EXPERIENCE Wake Forest University Health Sciences Course Director - Quantitate Organ Systems Physiology (BMES 606) Lecturer, Medical Imaging II (Instructed topics included chemistry and mechanism of contrast agents), (BMES 751) Lecturer, Drug Discovery, Design and Development (Instructed topics included: Adsorption, Distribution, Metabolism, Excretion, and Controlled Release) (CHM 740) Lecturer, Introduction to Regenerative Medicine (Drug Delivery in TERM), (BMES 631) Lecturer, Engineering Approaches to Understanding, Diagnosing, and Treating Cancer (Cancer Nanotechnology) Lecturer, Topics in Cancer Biology (Cancer Imaging) (MCB 723) Project Advisor, Regenerative Medicine (Craniofacial Reconstruction) (MCB 753) Emory - Georgia Tech Biomedical Engineering Senior Design Project; Rigid Bronchoscope Design for Real-Time In Vivo Acquisition and Analysis of Quantum Dot Images at Cellular and Tissue Levels. Teaching Assistantships Molecular Imaging; assisted in teaching fundamentals of clinical imaging modalities, emphasis on imaging probes and contrast agents (University of Utah) Drug Stability; assisted in teaching kinetics and mechanisms of organic reactions, structure reactivity relationships of pharmaceutical systems, degradation and stabilization of drugs, proteins, and DNA/RNA (University of Utah) Organic Chemistry; taught basic laboratory methods in organic chemistry, maintained 300 MHz NMR (St. John’s University/College of St. Benedict) Biochemistry; taught basic laboratory methods in biochemistry, gravity and electrophoresis separations, fluorescence spectrophotometry (St. John’s University/College of St. Benedict) Aaron M. Mohs, Ph.D. - 5 Research Training Program Mentorship Wake Forest Institute for Regenerative Medicine Summer Scholars Program University of Utah ACCESS program for women in science and mathematics University of Utah Summer Undergraduate Research Program (Pharmaceutics) SERVICE National Service Special Emphasis Panel (2015/05 ZCA1 TCRB-Q (M1)), Centers for Cancer Nanotechnology Excellence (CCNE), Bethesda, MD (2015) Scientific Review Panel, Maryland Stem Cell Research Fund, Baltimore MD (2013-current) Scientific Review Panel, NYSTEM Program, Reston VA (2013) Biomedical Engineering Society (BMES); Session Chair - Cancer Imaging (2012); Abstract Reviewer - Cancer Technologies (2013,2014) Invited Faculty Panelist on Career Development at the Biomaterials Gordon Research Seminar, Holderness, NH, July 2013 Tissue Engineering and Regenerative Medicine International Society; Regenerative Imaging and Sensing Working Group Vice-Chair; Wake Forest Institute of Regenerative Medicine Young Investigator Award Selection Committee Chair (2013); Abstract Reviewer - Imaging Technologies (2013) Chair, Nanomaterials/nanoformulations Working Group, NCI Alliance for Nanotechnology in Cancer (2011-2012) Participant in two NCI working groups to set standards for nanotechnology as a chemical and biological technology for cancer informatics, detection, and treatment (2007-2010) Participant in NIST-ASTM sponsored interlaboratory study (ILS) on nanotechnology standardization (2008) Institutional and Community Service 2013-2015 BMES Wake Forest Student Chapter Faculty Advisor 2011-2015 SBES Faculty search committee 2012-2015 WFIRM Department Animal Care and Use Committee Reviewer 2012 Science fair evaluator - Sherwood Forest Elementary (Winston-Salem, NC) Ad Hoc Reviewer (Impact Factor) ACS Nano (12.062) Analytical Chemistry (5.856) Biomaterials (7.404) Colloids and Surfaces B: Biointerfaces (3.456) Aaron M. Mohs, Ph.D. - 6 Journal Biomedical Applications (2.082) Nature Nanotechnology (27.27) Pharmaceutical Research (4.742) PLOS ONE (4.092) Translational Research (2.986) DISCLOSURES/PATENTS 1. Mohs AM, Hill TK, Kridel S. Application Number 62/028,968 (July 25, 2014) FAS Inhibitors and Methods Associated Therewith. 2. Mohs AM, Hill TK, Kelkar S. Application Number 62/026,078 (July 18, 2014) Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-Guided Surgery and Drug Delivery Vehicles and Methods Associated Therewith. 3. Nie S, Mohs AM, Mancini MC. Intraoperative Imaging Instrumentation for Visualizing Red, Deep-Red, and Near Infrared Fluorescent Probes Excited by Violet Light. (Disclosure: 6/8/11) 4. Nie S, Mohs AM, Mancini MC. SpectroPen and Integrated Widefield Imaging System Can Detect Atherosclerosis in a Mouse Model. (Disclosure: 2/1/11) 5. Nie S, Mohs AM, Mancini MC. (Provisional Filed 11/11/2011) US 13/295,662. Additional systems and methods for providing real-time anatomical guidance in a diagnostic or therapeutic procedure. 6. Nie S, Mohs AM, Mancini MC. PCT/US2010/060586 - Filed in AU, CA, CN, EU, IN, JP. Integrated Imaging and Spectroscopy Systems for Image-Guided Surgery. 7. Zong Y, Lu ZR, Mohs AM, Feng Y. Application number 60/814,449 (June 16, 2006). Biodegradable macromolecular MRI contrast agents and methods of preparation and use thereof. PEER-REVIEWED PUBLICATIONS 1. Stevenson AT, Reese LM, Hill TK, McGuire J, Mohs AM, Shekhar R, Bickford LR, Whittington AR. Fabrication and Characterization of Medical Grade Polyurethane Composite Catheters for Near-Infrared Imaging. Biomaterials. In Press. 2. Hill TK, Abdulahad A, Kelkar SS, Marini FC, Long TL, Provenzale JM, Mohs AM. Indocyanine Green-Loaded Nanoparticles for Image-Guided Tumor Surgery. Bioconj. Chem. In Press. PMID: 25565445. 3. Mohs AM*, Mancini MC, Provenzale JM, Saba CF, Cornell KK, Howerth EW, Nie S. An integrated widefield imaging and spectroscopy system for contrast-enhanced, imageguided resection of tumors. IEEE Trans. Biomed. Eng. In Press. PMID: 25585410 *Corresponding author. Cover and Feature Article. Press Coverage: http:// www.sciencedaily.com/releases/2015/01/150120142555.htm; http:// Aaron M. Mohs, Ph.D. - 7 www.photonicsonline.com/doc/scientists-invent-system-to-improve-effectiveness-ofcancer-surgery-0001; WSJS Interview 4. Niu G, Sapoznik E, Lu P, Criswell T, Mohs AM, Wang G, Lee SJ, Xu Y, Soker S. Fluorescent imaging of cells in bioengineered blood vessels; the impact of cross-linking of the scaffold. J. Tissue Eng. Regen. Med. (Accepted). PMID: 24616385. 5. Opie AMT, Bennett JR, Walsh M, Rajendran K, Yu H, Xu Q, Butler A, Butler P, Cao G, Mohs AM, Wang G. (2014) Study of scan protocol for exposure reduction in hybrid spectral micro-CT. Scanning. 36(4):444-455. PMID: 24604215. 6. Bennet JR, Opie AMT, Xu G, Yu H, Walsh M, Butler A, Butler P, Cao G, Mohs A, Wang G. (2014) Hybrid true-color micro-CT: system design, implementation & preliminary results. IEEE Trans. Biomed. Eng. 61(2):246-253. PMID: 23996533 7. Mohs AM*, Mancini MC*, Provenzale JM, Singhal S, Leyland-Jones B, Wang MD, Nie S. (2010) Hand-held spectroscopic device for in vivo and intraoperative tumor detection: contrast enhancement, detection sensitivity, and tissue penetration. Anal. Chem. 82(21): 9058-9065. *Denotes equal contribution. PMID: 20925393 8. Provenzale JM, Mohs AM. (2010) Nanotechnology in neurology-current status and future possibilities. US Neurology 6(1):12-17. 9. Mohs AM, Provenzale JM. (2010) Applications of nanotechnology to imaging and therapy of brain tumors. Neuroimag. Clin. N. Am. 20(3):283-292. PMID: 20708547 10. Mohs AM, Duan HW, Kairdolf BA, Smith AM, Nie S. (2009) Proton-resistant quantum dots: stability in gastrointestinal fluids and implications for oral delivery of nanoparticle agents. Nano. Res. 2:500-508. PMID: 20379372 11. Smith AM, Mohs AM, Nie S. (2009) Tuning the optical and electronic properties of semiconductor nanocrystals by lattice strain. Nat. Nanotech. 4(1):56-63. PMID: 19119284 12. Feng Y, Jeong EK, Mohs AM, Emerson L, Lu ZR. (2008) Characterization of tumor angiogenesis with dynamic contrast-enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice. Magn. Reson. Med. 60(6):1347-1352. PMID: 19025902 13. Smith AM, Duan HW, Mohs AM, Nie S. (2008) Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug. Deliv. Rev. 60(11):1226-1240. PMID: 18495291 14. Mohs AM, Nguyen T, Jeong EK, Feng Y, Emerson LL, Zong Y, Parker DL, Lu ZR. (2007) Pegylation of Gd-DTPA cystine copolymers optimizes pharmacokinetics and tissue retention for magnetic resonance angiography. Magn. Reson. Med. 58(1):110-118. PMID: 17659618 15. Mohs AM, Lu ZR. (2007) Gadolinium(III)-based blood pool contrast agents for magnetic resonance imaging: current status and clinical potential. Expert Opin. Drug. Deliv. 4(2): 149-164. PMID: 17335412 16. Zong Y, Guo J, Ke T, Mohs AM, Parker DL, Lu ZR. (2006) Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes. J. Control. Release 112:350-356. PMID 16631270 Aaron M. Mohs, Ph.D. - 8 17. Lu ZR, Mohs AM, Zong Y, Feng Y. (2005) Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents. Intl. J. Nanomed. 1:31-40. PMID: 17722260 18. Mohs AM, Zong Y, Guo J, Parker DL, Lu ZR. (2005) PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI. Biomacromolecules 6:2305-2311. PMID: 16004476 19. Zong Y, Wang X, Goodrich KC, Mohs AM, Parker DL, Lu ZR. (2005) Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice. Magn. Reson. Med. 53:835-842. PMID: 15799038 20. Mohs AM, Wang X, Zong Y, Goodrich KC, Parker DL, Lu ZR. (2004) PEG-g-poly(GdDTPAco-L- cystine): A biodegradable macromolecular blood pool contrast agent for MR imaging. Bioconj. Chem. 15:1424 - 1430. PMID 15546211 PUBLICATIONS SUBMITTED OR IN PREPARATION Submitted 21. Provenzale JM, Mancini, MC, Mohs AM, Saba C, Cornell K, Howerth E, Nie S. Intraoperative optical imaging using a very low dose of indocyanine green contrast agent. Manuscript Under Review. In Preparation 22. Hill TK, Davis A, Wheeler, F, Kridel SJ, Mohs AM. Orlistat-Containing Nanoparticles: Loading Efficiency, Cytotoxicity, and Fatty Acid Synthase Inhibition. Expected Submission Jan-Feb 2015 23. Kelkar SS, Hill TK, Gao X, Marini FC, Mohs AM. Hyaluronan-Cy7.5 conjugates: effect on self-assembly, optical properties, and enhancement of tumor cells. Expected Submission - JanFeb 2015 ORAL PRESENTATIONS 1. Mohs AM. Near Infrared Fluorescent Nanoparticles for Image-‐‑Guided Tumor Surgery; Invited Seminar; Pharmaceutical Sciences, University of Nebraska Medical Center; Omaha, NE, December 2014. 2. Mohs AM, Hill TK, Kelkar SS, Marini FC, Levine, E. Hyaluronic Acid Derived Nanoparticles with Activatable Fluorescence for Image-‐‑Guided Tumor Surgery; Biomedical Engineering Society Annual Meeting; San Antonio, TX, October 2014. 3. Mohs AM, Raghavan S, Gilmont R, Somara S, Marini FC, Bitar KN. Near Infrared Fluorescent Neural Progenitor Cells to Track Differentiation and Tissue Innervation; Biomedical Engineering Society Annual Meeting; San Antonio, TX, October 2014. 4. Mohs AM. Nanotechnology for Minimally Invasive Cancer Detection and Resection; NCI Alliance for Nanotechnology in Cancer Investigators Meeting; Rockville, MD, October 2014. 5. Mohs AM. Nanotechnology for Image-‐‑Guided tumor Surgery; Invited Seminar; Biomedical Engineering, University of South Dakota; Sioux Falls, SD, September 2014. Aaron M. Mohs, Ph.D. - 9 6. Mohs AM. Hyaluronic Acid Derived Nanoparticles for Image-‐‑Guided Surgery and Drug Delivery; Invited Seminar, Chemistry, Wake Forest University; Winston-‐‑Salem, NC, September 2014. 7. Mohs AM. Near Infrared Fluorescent Protein Labeling of Enteric Nerve Cells: Development and Initial Characterization of IM-‐‑FEN-‐‑iRFP Cells, North Carolina Tissue Engineering and Regenerative Medicine Society Annual Meeting; Winston-‐‑Salem, NC, October 2013. 8. Mohs AM. Nanotechnology for Image-‐‑Guided Intervention: Potential for Prostate Cancer?, Prostate Cancer Research and Translation Symposium; Winston-‐‑Salem, NC, March 2013. 9. Mohs AM. Nanotechnology for Emerging Biomedical Applications, Invited Seminar at the Joint School for Nanoscience and Nanoengineering at UNC Greensboro and NC A&T, Greensboro, NC, November 2012. 10. Mohs AM, Mancini MC, Qian X, Wang Y, Provenzale JM, Nie S. Nanotechnology for Guided Tumor Resection, NCI Alliance for Nanotechnology in Cancer Investigators Meeting; Houston, TX, November 2012. 11. Mohs AM, Wang Y, Qian X, Mancini MC, Provenzale J, Nie S. Nanotechnology for Spectroscopic and Image-Guided Tumor Resection, Biomedical Engineering Society Annual Meeting; Atlanta, GA, October 2012. 12. Mohs AM. Tumor cell marker imaging: searching for the micrometastases that change the game, RSNA/ASTRO Cancer Imaging and Radiation Therapy Symposium; Atlanta, GA, April 2011 (copresenters Provenzale JM and Mancini MC). 13. Mohs AM. Nanotechnology for medical and surgical imaging: current status and future possibilities, Invited speaker for Duke Radiology Grand Rounds; Durham, NC, January 2011 (co-presenter Provenzale JM). 14. Mohs AM. Wide-field optical imaging with interactive excitation and spectroscopy to resect contrast-enhanced tumors, Invited speaker at Northeastern University; Boston, MA, January 2011. 15. Mohs AM. Wide-field optical imaging using point excitation and spectroscopy for imageguided resection of contrast-enhanced tumors, Invited speaker at UT Southwestern Medical Center; Dallas, TX, November 2010. 16. Mohs AM. Quantum dots for cellular and molecular imaging: unusual optical properties and cellular toxicity, Invited speaker at UT Dallas; Richardson, TX, November 2010. 17. Mohs AM. Laser-guided widefield imaging and spectroscopy for guidance during surgical resection of tumors, Fitzpatrick Institute for Photonics Annual Meeting; Duke University, Durham, NC, October 2010 (co presenters Mancini MC, Provenzale JM). 18. Mohs AM, Mancini MC, Provenzale JM, Singhal S, Wang MD, Nie S. A hand-held imaging and spectroscopy device for intraoperative, contrast-enhanced tumor detection, Biomedical Engineering Society Annual Meeting; Austin, TX, October 2010. Aaron M. Mohs, Ph.D. - 10 19. Mohs AM. Integrated Spectroscopy and Imaging for Intraoperative Cancer Detection and Surgical Oncology, Invited seminar at Case Western Reserve University; Cleveland, OH, January 2010. 20. Mohs AM, Raza SH, White, WB, Kaddi C, Mancini MC, Nie S, Wang MD, Singhal S. The development of a novel endoscope to visualize residual tumor cells following cancer surgery, American College of Surgeons 95th Annual Clinical Congress; Chicago, IL, October 2009. 21. Mohs AM, Smith AM, Mancini MC, Wen MM, Nie S. Investigating the Interactions, Consequences, and Applications of Nanoparticles at Biological Interfaces, NCI Alliance for Nanotechnology in Cancer Investigators Meeting; Chicago, IL, September 2008. 22. Mohs AM, Zong Y, Goodrich KC, Parker DL, Lu ZR. PEG-g-(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI, Utah Center for Advanced Imaging Research 17th Annual Symposium; Salt Lake City, UT, October 2005. 23. Mohs AM, Zong Y, Parker DL, Lu ZR. PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI. MR Angio Club - The 17th Annual International Conference on Magnetic Resonance Angiography; Beijing, China, September 2005. 24. Mohs AM, Zong Y, Feng Y, Guo J, Parker DL, Lu ZR. PEG-g-(GdDTPA-co-L-cystine): novel biodegradable macromolecular contrast agents for MRI, Controlled Release Society Annual Meeting, 32nd Annual Meeting & Exposition of the Controlled Release Society; Miami, FL, June 2005. 25. Mohs AM, Wang X, Zong Y, Goodrich KC, Parker DL, Lu ZR. PEG-g-(GdDTPA-co-Lcystine):a biodegradable macromolecular contrast agent for blood pool MR imaging, Utah Center for Advanced Imaging Research 16th Annual Symposium; Park City, UT, November 2004. CO-AUTHORED CONFERENCE ABSTRACTS 1. Kelkar SS, Hill TK, Mohs AM. Hyaluronic Acid Derived Fluorescent Imaging Agents with Tunable NIR Emission. Biomedical Engineering Society Annual Meeting; San Antonio, TX, October 2014. 2. Hill TK, Wheeler FB, Davis AL, Kelkar SS, Kridel SE, Mohs AM. Development of a Nanoparticle Formulation or Orlistat: Solubility, Stability, and Cytotoxicity. Biomedical Engineering Society Annual Meeting; San Antonio, TX, October 2014. 3. Kelkar SS, Hill TK, Gao X, and Mohs AM. CD-44 Targeted Biodegradable Nanoparticles for Image-Guided Surgery. NanoDDS, 12th International Nanomedicine & Drug Delivery Symposium, Chapel Hill, NC, October 2014. 2. Hill TK, Kelkar S, Marini FC, Levine EA, Provenzale JM, Mohs AM. Synthesis, Characterization, and Pre-Clinical Evaluation of Hyaluronan Based Nanoparticles for Image-Guided Surgery. Duke University Fitzpatrick Institute for Photonics Annual Symposium, Durham, NC, March 2014. Aaron M. Mohs, Ph.D. - 11 3. Rowe B, Mohs AM, Christ GJ, Harrison BS. Functional Recovery and Tissue Salvage in Ischemic Injury Using Non-Invasive MRI as a Tool to Quantify the Extent of Tissue Damage in a Rodent Ischemic Injury Model. North Carolina Tissue Engineering and Regenerative Medicine Society Annual Meeting; Winston-Salem, NC, October 2013. 4. Hill TK, Kelkar S, Marini FC, Mohs AM. Near Infrared Fluorescent Polysaccharide-Based Nanoparticles for Image-Guided Tumor Surgery. NCI Alliance for Nanotechnology in Cancer Annual Principal Investigators Meeting; Bethesda, MD, September 2013. 5. Hill TK, Marini FC, Mohs AM. Near infrared image-guided tumor removal: epidermal growth factor receptor as a target, Biomedical Engineering Society Annual Meeting; Atlanta, GA, October 2012. 6. Smith AM, Mohs AM, Nie S. Strain-tunable, near infrared quantum dots for in vivo molecular imaging, Society for Molecular Imaging; Providence, RI, September 2007. 7. Zong Y, Guo J, Feng H, Sun Y, Mohs AM, Parker DL, Lu ZR. (Gd-DTPA)-cystine diethylester copolymers (GDCEP) as a biodegradable contrast agent for MR imaging, Controlled Release Society Symposium; Salt Lake City, UT, February 2005. 8. Zong Y, Wang X, Mohs AM, Goodrich KC, Lu ZR. MR imaging of a biodegradable polymeric contrast agent, cystine-DTPA-Gd complex. Controlled Release Society; Honolulu, HI, June 2004. 9. Zong Y, Mohs AM, Goodrich KC, Wang X, Parker DL, Lu ZR. Synthesis of Gd(III) DTPAcystine a Gd(III) DTPA-cystine ethyl ester copolymers for MRI, Imaging in 2020; Jackson Hole, WY, September 2003. 10. Tekavek TN, Brueske CJ, Mohs AM, Westman AL, Schaller CP. Synthesis of molybdenum complexes of DACO’ and pzpy’. 223rd ACS National Meeting; Orlando, FL, April 2002. POSTER PRESENTATIONS 1. Mohs AM, Hill TK, Long TE, Marini FC, Levine EA. Targeted Near Infrared Fluorescent Nanoparticles for Image-‐‑Guided Tumor Surgery, Drug Carriers in Medicine and Biology Gordon Research Conference; Waterville Valley, NH, August 2014. 2. Mohs AM, Hill TK, Kelkar S, Marini FC, Levine EA. Hyaluronic acid derived fluorescent nanoparticles for image-‐‑guided tumor surgery, 41st Controlled Release Society Annual Meeting & Exposition; Chicago, IL, July 2014. 3. Mohs AM, Raghavan S, Gilmont RR, Somara S, Marini FC, Bitar KN. Near infrared labeling and detection of enteric nerve cells: tracking differentiating neural progenitor cells and tissue innervation, Tissue Engineering and Regenerative Medicine International Society -‐‑ Americas; Atlanta, GA, November 2013. 4. Mohs AM, Zarifpour M, Kelkar S, Kahlson MA, Marini FC, Christ GJ. Magnetic Resonance Imaging Characterization of Regenerating Bladder in a Murine Subtotal Cystectomy Model, Tissue Engineering and Regenerative Medicine International Society -‐‑ Americas; Atlanta, GA, November 2013. Aaron M. Mohs, Ph.D. - 12 5. Mohs AM, Wang Y, Mancini MC, Provenzale JM, Singhal S, Nie S. Intraoperative detection of fluorescent nanoparticles using a handheld spectroscopic pen device to guide tumor resection, AACR Special Conference on Nano in Cancer: Linking Chemistry, Biology, and Clinical Applications In Vivo; Miami, FL, January 2011. 6. Mohs AM, Singhal S, Nie S. Nanotechnology for minimally invasive cancer detection and resection, Kick-off Meeting - NCI Alliance for Nanotechnology in Cancer; Bethesda, MD, November 2010. 7. Mohs AM, Smith AM, Mancini MC, Provenzale JM, Nie S. The unusual chemistry and cellular toxicity of cadmium-free quantum dots, Fitzpatrick Institute for Photonics Annual Meeting; Duke University, Durham, NC, October 2010. 8. Mohs AM, Smith AM, Mancini MC, Wen MM, Nie S. Evaluating the Role of Chemical Composition and Colloidal Stability on Quantum Dot Cytotoxicity, NCI Alliance for Nanotechnology in Cancer Investigators Meeting; Chicago, IL, September 2008. 9. Mohs AM, Smith AM, Mancini MC, Nie S. Investigation into the toxicology of straintunable quantum dots, NCI Alliance for Nanotechnology in Cancer Investigators Meeting; Chapel Hill, NC, October 2007. 10. Mohs AM, Wang X, Zong Y, Goodrich KC, Parker DL, Lu ZR. Gd(III)DTPA-L-cystine-PEG copolymers: a biodegradable macromolecular agent for blood pool MR imaging, International Society of Magnetic Resonance in Medicine - 12th Scientific Meeting and Exposition; Kyoto, Japan, May 2004. PROFESSIONAL AFFILIATIONS American Chemical Society (ACS) Biomedical Engineering Society (BMES) Controlled Release Society (CRS) Institute of Electrical and Electronics Engineers (IEEE) IEEE Engineering in Medicine and Biology Society (IEEE-EMBS) Tissue Engineering and Regenerative Medicine International Society (TERMIS) World Molecular Imaging Society (WMIS) MENTORSHIP Postdoctoral Research Associates Dr. Sneha Kelkar, PhD Doctor of Philosophy Tanner Hill* (BME), PhD Candidate - Thesis Advisor - Expected PhD 2015 *2014-2015 Mike and Lucy Robbins Fellowship Award for academic, research, and leadership excellence Elizabeth Graham (BME), PhD Candidate - Thesis Committee co-chair Jasmine Brown (BME) - Thesis co-Advisor Hannah Baker (BME) - Thesis Committee Member Aaron M. Mohs, Ph.D. - 13 Laura Hernandez-Cruz (BME) - Thesis Committee Member Riu Wang (BME) - Thesis Committee Member Etai Sapoznik (BME) - Thesis Committee Member John P. McQuelling (BME) - Thesis Committee Member John Scott (BME) - Thesis Committee Member - PhD 2015 Benjamin Rowe (Physiology/Pharmacology) - Thesis Committee Member Christopher Stuart (Molecular Medicine) - Thesis Committee Member Stephen Vance (Nanotechnology program at UNCG)— Thesis Committee Member Master of Science William Payne (BME) - Thesis Advisor Abayomi Adeyemi - Committee Member Riu Wang - Thesis Committee Member - MS 2012 Undergraduate Research Assistants Erica Freund - Honors Thesis Advisor - Wake Forest University (Physics) - current Gillian Lloyd - Wake Forest University (Biology) - Fall 2013 - Fall 2014 Joshua Copus - Clemson University (WFIRM Summer Scholar) - Summer 2014 Xiangxi Gao - Emory University (Biomedical Engineering Summer Scholar) - Summer 2014 Kindell Schmitt - Virginia Tech (Biological Systems Engineering) - Summer 2014 Martha Kahlson - Mount Holyoak College (Biochemistry) - Summer 2013 Robert C. Johnson, II - Johnson C. Smith University (Biology) - Summer 2013 Florence McCarty - Johnson C. Smith University (Biology) - Summer 2012